GCK3 Therapeutics AB
ActiveKey figures
Key figures
2024/25Summary: GCK3 Therapeutics AB
What kind of company is it?
GCK3 Therapeutics AB (org. no. 559072-1428) is a limited company (AB). The company was registered in 2016 and has existed for 10 years. Registered seat: Göteborg. Industry according to Statistics Sweden: leasing of intellectual property and similar products, except copyrighted works (SNI 77400).
How is the company doing financially?
The company had no net sales in financial year 2025. Financial year 2025 ended with a loss of 12 419 kr. The company was profitable in 2 of the 3 reported financial years. At the end of financial year 2025, total assets were 41 669 kr and equity 41 317 kr (equity ratio 99,2 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Summary of annual reports2023–2025
| 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|
| Sales revenue | 0 | 0 | 0 |
| Profit for the reporting year | 154 620 | 1 466 | −12 419 |
| Retained earnings of previous periods | — | — | — |
| Total assets | 416 464 | 54 088 | 41 669 |
| Total liabilities | 54 595 | 352 | 352 |
| Total equity | 361 869 | 53 736 | 41 317 |
| Employees | — | — | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.